Edward Gerstenfeld, MD
|School||UCSF School of Medicine|
|Address||500 Parnassus Avenue|
San Francisco CA 94117
|University of California, San Francisco||Clinical Fellowship ||School of Medicine - Cardiology|
|Northwestern University||M.D.||1993||School of Medicine|
1) Treatment of atrial fibrillation (including catheter ablation of paroxysmal and persistent atrial fibrillation); mapping and ablation of atrial tachycardias/flutters that occur after AF ablation;
2) Treatment and ablation of supraventricular tachycardias (atrial tachycardia, atrial flutter, AV node reentry, Wolff-Parkinson-White syndrome);
3) Mapping and ablation of ventricular tachycardia in patients with normal hearts, and in patients ischemic and nonischemic cardiomyopathy (including epicardial mapping and ablation).
4) Treatment of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC), including endocardial and epicardial mapping and ablation.
5) Treatment of patients with inherited arrhythmia syndromes including long QT syndrome (LQTS), catecholaminergic VT (CPVT), Brugada syndrome, hypertrophic cardiomyopathy
RESEARCH INTERESTS: Dr Gerstenfeld's laboratory is interested in better understanding the mechanism of atrial fibrillation using signal processing an humans and preclinical models. Dr Gerstenfeld has also worked in the preclinical and clinical lab developing new technology for the ablation of arrhythmias, including working with cryoablation and laser ablation. He has also worked with developing better imaging techniques for identifying scar before and after ablation using delayed enhancement cardiac MRI. Finally he has worked in the preclinical lab with models of ischemic ventricular tachycardia and pacing induced cardiomyopathy in order to better understand the mechanism of cardiomyopathy causes by premature ventricular beats.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.